PharmaGuide vs EMDEX Reference
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
PharmaGuide
This medical reference app provides instant and predictive search for drug information, including brand, generic, and content names. It features an interaction checker to identify potential drug conflicts and offers detailed information on dosages, administration, risk factors, and adverse effects.
- Instant drug search by brand, generic, or content
- Predictive search functionality
- Drug interaction checker
- Detailed risk factors and contraindications
- Accurate dosage information by indication
- Drug administration and preparation guides
- Alternate product suggestions
Read full descriptionHide full description
PharmaGuide Instant and Predictive Search by: Brand Company Name Generic Name (e.g. Cefoperazone) Contents (e.g. Cefoperazone and Sulbactam) Therapeutic Category (e.g. Cephalosporins) Interaction Checker: Interaction Checker feature lets you quickly identify any interactions among prescribed drugs. You can select GENERICS as well as BRANDS in your country to check interaction. Risk Factors Information provided under Risk Factors include Contraindications, Precautions and Risks in Pregnancy and Lactation for the relevant product. Pregnancy: Risk cannot be ruled out. Lactation: Contraindicated. Contraindications: Severe respiratory depression, severe obstructive lung conditions. Precautions: COPD, raised intracranial pressure, impaired consciousness, head injury, bradyarrhythmia, renal or hepatic impairment. Monitor for signs of respiratory depression. Brain tumour. Risk of tolerance and dependence. Elderly or debilitated patients. Dosage (Alongwith Indications) Fast, Quick & Easy Access to Accurate Dosage in Specific Indications The usual dosage are: Adults: Usually 1 gm daily by deep IM., slow IV inj over at least 2-4 min, or IV infusion. Severe infections, 2-4 gm as a single dose every 24 hrs. Children: Usually 20-50 mg/kg once daily by IM inj., slow IV inj over at least 2-4 min, or IV infusion. Severe infections, up to maximum 80 mg/kg daily. Doses over 50 mg/kg to be given by slow IV infusion over at least 30 minutes. Neonates: IM/IV: Postnatal age ≤ 7 days or > 7 days (body wt ≤ 2 Kg): 50 mg/kg/day given every 24 hrs. Postnatal age > 7 days, body wt > 2 Kg: 50-75 mg/kg/day given every 24 hrs. Administration How to prepare and administer e.g. an Injectable The drug may be administered by IV intermittent infusion over 10-30 min; final concentration for IV administration should not exceed 40 mg/mL. The drug has also been administered by direct IV push over 2-4 min. Inject deep IM into large muscle mass. IM Injection: 250 mg/500 mg/1000 mg VIAL: To make concentration of 250 mg/mL add Water for Injection 0.9 mL in 250 mg vial; 1.8 mL in 500 mg vial; 3.6 mL in 1000 mg vial. IV: 250 mg/500 mg/1000 mg VIAL: To make concentration of 100 mg/mL add Water for Injection 2.4 mL in 250 mg vial; 4.8 mL in 500 mg vial; 9.6 mL in 1000 mg vial. Compatibility: Stable in D5W, D10W, NS, Sodium bicarbonate 5%, bacteriostatic water, SWFI. Stability: For IV infusion in NS or D5W, solution is stable for 3 days at room temperature or 10 days when refrigerated. Interactions Amikacin, Aminoglycosides, Anticoagulants, Gentamicin, Kanamycin, Neomycin, Netilmicin, Streptomycin, Tobramycin, Warfarin. Adverse Effects GI upset, skin reactions, blood dyscrasias. Rarely pseudomembranous colitis, raised liver enzymes, glycosuria, oliguria, haematuria, bronchospasm, phlebitis at inj site, urinary and biliary precipitates, pancreatitis. Alternate Products Quickly find Alternate Products - Just Click the Appropriate Button e.g. Searching for an Alternative of Amaryl
EMDEX Reference
This app provides comprehensive drug and therapeutic information for Nigeria, including essential medicines, treatment guidelines, and drug product details. It features an interaction checker, diagnosis and management of prevalent diseases, and a natural health products compendium. Designed for healthcare professionals, it offers enhanced search and detailed drug information.
- Comprehensive drug product database
- Essential Medicines List
- Standard Treatment Guideline recommendations
- Interaction checker
- Natural health products compendium
- Diagnosis and management of prevalent diseases
- Rapid drug news and safety alerts
Read full descriptionHide full description
EMDEX (Essential Medicines Index) is Nigeria’s trusted source for drug and therapeutic information published since 1991. Based on both the WHO Model Formulary and Nigeria’s Essential Medicines Lists, EMDEX is unique to Nigeria as it also details over 15000 drug products approved for use in the country. EMDEX App has several unique functionalities, practice resources & tools including: 1. Nigeria's most comprehensive & regularly updated Drug Product Database 2. Nigeria's Essential Medicines List (EML & EMLc) 3. NSTG (Nigeria's Standard Treatment Guideline) Recommendations under the drug details 4. Dental Formulary 5. Therapeutic Notes 6. Compendium of Natural Health Products 7. Diagnosis & Management of Prevalent Diseases in the country 8. Interaction Checker 9. RapidRx – Keep up-to-date with latest drug news, safety alerts & recalls. 10. Indication Index, etc. EMDEX is for healthcare professionals only. Other key features: - Enhanced Search Functionality (Search by Brand, Generic or Indication). - Easy to navigate by Generics, Therapeutic Classes, Indications. - Drugs details featuring Adult & Child Dosages, Renal Dose, Administration, Pharmacovigilance, Advice to Patients, Nursing Action, Drug Use in Pregnancy & Lactation, Drug product descriptions & Pack sizes, etc. - Favourite Drugs (Build your Formulary by Bookmarking your favourite drugs) - Feedback (You can directly post your valuable suggestions, advice & comments) Disclaimers EMDEX Mobile Drug Reference & Therapeutic Notes is to be used only as a reference aid and educational purpose and is not intended for medical advice, diagnosis or treatment. It is neither intended to be a substitute for the exercise of professional judgment and should not be relied upon solely for final treatment decisions. The clinical information contained in the App is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. We used reliable & authentic data sources and company literatures. Although great effort has been made in compiling and checking the information contained in this app to ensure that it is accurate, the publisher, the authors, editors and their servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions or inaccuracies in this app whether arising from negligence or otherwise howsoever, or for any consequences arising there from. A LICENSED MEDICAL PROFESSIONAL IS RESPONSIBLE FOR INDEPENDENTLY REACHING ANY MEDICAL JUDGMENT, AND FOR ANY RESULTING DIAGNOSIS AND TREATMENTS, NOTWITHSTANDING ANY USE OF THE CONTENT BY SUCH MEDICAL PROFESSIONAL. BY USE OF THIS APP YOU ACKNOWLEDGE AND AGREE THAT THE INFORMATION ON THIS APP MAY CONTAIN INACCURACIES AND OTHER ERRORS. Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Screenshots
Verdict
The clearest difference is rating: EMDEX Reference at 4.7 against PharmaGuide's 3.3. PharmaGuide's advantage is in-app purchases (none vs 3) and ads (none vs shown). On price, review sentiment and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. EMDEX Reference sells 3 in-app purchases, starting at $0.99 per 7 days. PharmaGuide asks for nothing beyond the download.
EMDEX Reference holds the better App Store score, 4.7 against 3.3. Both are backed by a comparable volume of ratings — 9 and 3 respectively. Written reviews point the same way: 44% of PharmaGuide's written reviews are positive against 50% of EMDEX Reference's.
PharmaGuide ships an update every 2 months, EMDEX Reference every 5 months. The most recent releases landed on September 9, 2026 and September 10, 2026 respectively.
| Parameter | PharmaGuide | EMDEX Reference |
|---|---|---|
| Price | Free | Free |
| Rating | 3.3 (9 ratings) | 4.7 (3 ratings) — better |
| Positive reviews | 44.4% of reviews | 50.0% of reviews — better |
| Number of ratings | 9 — better | 3 |
| Update frequency | Every 2 months — better | Every 5 months |
| Ads | No — better | Yes |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Ad-supported |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 — better | 15.6 |
| Further details — not scored | ||
| Size | 60 MB | 53 MB |
| Age rating | 4+ | 17+ |
| Developer | PharmaGuide Systems | EMDEX Limited |
Customer experience
PharmaGuide
EMDEX Reference
In-app purchases
PharmaGuide
No in-app purchases
EMDEX Reference
- Weekly Plan$0.997 Days
- Querterly Plan$6.993 Months
- Yearly Plan$24.991 Year
Questions
Is PharmaGuide free?
Is EMDEX Reference free?
Which has better reviews, PharmaGuide or EMDEX Reference?
Do PharmaGuide or EMDEX Reference have ads?
Which is updated more often, PharmaGuide or EMDEX Reference?
Other comparisons















